RESUMO
A 55-year-old man had a myelopathic syndrome and serologic evidence of Epstein-Barr virus infection. The patient's age and the neurologic and serologic findings suggested reactivation of a latent virus with direct invasion of the CNS. Epstein-Barr virus may exist in a latent state within the nervous system, and should be considered in myelopathic syndromes, even in older patients.
Assuntos
Infecções por Herpesviridae/complicações , Doenças da Medula Espinal/complicações , Anticorpos Antivirais/análise , Infecções por Herpesviridae/imunologia , Herpesvirus Humano 4 , Humanos , Masculino , Pessoa de Meia-Idade , Doenças da Medula Espinal/imunologiaAssuntos
Doenças dos Nervos Cranianos/etiologia , Movimentos Oculares , Infecções por Herpesviridae/complicações , Adolescente , Corticosteroides/uso terapêutico , Doenças Cerebelares/etiologia , Doenças dos Nervos Cranianos/diagnóstico , Eletronistagmografia , Feminino , Infecções por Herpesviridae/tratamento farmacológico , HumanosRESUMO
Distribution of antibodies to herpes simplex type 1 (HSV1), Epstein-Barr virus (EBV), cytomegalovirus (CMV) and measles virus (MV) was studied in sera and cerebrospinal fluids (CSF) of 41 patients with schizophrenia, 27 patients with primary affective disorders and 25 control patients with neurological diseases. No significant differences in distribution and mean geometric titers (GMT) of antibodies to HSV1 between the psychiatric and control groups were found. Distribution and GMT of antibodies to EBV were highly significant in psychiatric patients as compared to controls with highest titers in the affective disorder group. Antibodies to HSV1 were present in 15 CSF specimens of psychiatric patients with reduced CSF/serum ratio in 4, and low levels of antibodies were detected in 8 control patients. Antibodies to EBV-VCA were detected in 4 CSFs of psychiatric patients. Total protein levels were determined in CSF specimens and no correlation with antibodies was found. No significant differences in distribution of antibodies to CMV or MV in the three study groups were found. No antibodies to CMV were demonstrated in CSFs and in one specimen from a patient and two controls antibodies to MV were detected.
Assuntos
Anticorpos Antivirais/análise , Citomegalovirus/imunologia , Herpesvirus Humano 4/imunologia , Vírus do Sarampo/imunologia , Transtornos Psicóticos/imunologia , Simplexvirus/imunologia , Transtornos Psicóticos Afetivos/imunologia , Humanos , Transtornos Psicóticos/microbiologia , Esquizofrenia/imunologiaAssuntos
Encefalopatia de Wernicke/diagnóstico , Alcoolismo/complicações , Humanos , Distúrbios Nutricionais/complicações , Distúrbios Nutricionais/etiologia , Nutrição Parenteral/efeitos adversos , Deficiência de Tiamina/complicações , Deficiência de Tiamina/etiologia , Encefalopatia de Wernicke/etiologiaRESUMO
A survey of the incidence and prevalence of Crohn's disease in the Jewish population of Tel-Aviv-Yafo was carried out from 1970 to 1976. The annual incidence rate was 1.28, and the prevalence was 12.31 per 10(5) population. The prevalence of 16.69 per 10(5) population among Ashkenazi jews was significantly higher than that found in "non-Ashkenazi" Jews, 4.19 per 10(5) population. Even so, Crohn's disease is significantly less common in Tel-Aviv than outside Israel, according to most recently published surveys. Similarly, the complication, surgery, and mortality rate are less marked than those reported from other studies. These figures confirm the authors' impression that inflammatory bowel disease in general is less common and possible less severe in Tel-Aviv than in the United State and Western Europe. The strikingly higher prevalence in the Ashkenazi community, especially in the Israeli-born population, suggests a hereditary predisposition. The apparent differences among Askhenazi Jews in various parts of the world may relate to environmental factors.
